
A Step Change in the MenaQ7® Portfolio
Amidst the hustle and bustle of SupplySide West, the Gnosis team was excited to unveil our latest portfolio development – a turnkey immune product designed to bolster one’s foundational health, in a dose form that is meant to seamlessly support the fast-moving, quality-driven consumer. The product is a result of the successful partnership between Gnosis and Probiotcal.
This launch marks a significant milestone in the MenaQ7® journey: introducing a ready-to-market private label finished product. This step change presents brand owners with clear advantages, enabling them to bypass the often-time-consuming development phase and proceed directly to product launch. They can do so with the assurance that they are offering a science backed, branded ingredient in a well-formulated supplement, perfectly positioned for a targeted audience. The launch is a true testament to one of our guiding pillars: Come for K2 Science, Stay for the Partnership.
Gnosis Cocktail Party: A Chance to Re-Connect and Re-Explore
Latest news & videos

- MenaQ7®
- Mobility & Joint
- News
- Apr 29, 2025
FSANZ Approves Vitamin K2 for Food for Special Medical Purposes
The Food Standards Australia New Zealand (FSANZ) has officially approved the use of Vitamin...

- Lynside® Nutritional Yeasts
- News
- Wellness & Immune
- Apr 23, 2025
Lynside® Forte Se+ for Skin Protection Against Sun Exposure
Selenium yeast boosts skin defenses against sun damage by fighting oxidative stress, supporting repair,...

- MenaQ7®
- Mobility & Joint
- MyCondro®
- Apr 17, 2025
Successful Vital Nutrients Symposium:
Shaping the Future of Healthy Aging
The Vital Nutrients Symposium 2025, held in Kassel, Germany, offered an excellent platform to...